Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-04-25
2006-04-25
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S265800
Reexamination Certificate
active
07034047
ABSTRACT:
The invention relates to a triazole derivative with an activity inhibiting glycine transporter and for use as a pharmaceutical drug, and a novel triazole derivative. The inventive triazole derivative has an excellent activity inhibiting glycine transporter and is useful as a therapeutic agent of dementia, schizophrenia, cognitive disorders, or cognitive disorders involved in various diseases such as Alzheimer disease, Parkinson's disease, or Huntington disease or the like, or spasm involved in diseases such as nerve degenerative diseases and cerebrovascular disorders, or the like. Particularly, the pharmaceutical drug is useful for the amelioration of learning disability of dementia and the like.
REFERENCES:
patent: 2000-63363 (2000-02-01), None
patent: WO 01/58880 (2001-08-01), None
CA:135:180769 abs of WO 2001058880 Aug. 2001.
Arlt Michael
Greiner Hartmut
Hamaguchi Wataru
Kimizuka Tetsuya
Kohara Atsuyuki
Astellas Pharma Inc.
Lee Susannah E.
Saeed Kamal A.
Sughrue & Mion, PLLC
LandOfFree
Triazole derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazole derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazole derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3592405